AstraZeneca to acquire Alexion in $39 billion deal

Alexion shareholders will receive $60 in cash and 2.1243 AstraZeneca
American Depositary Shares per Alexion share.

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/astrazeneca-to-acquire-alexion-in-39-billion-deal/articleshow/79697059.cms

Comments

Popular posts from this blog

Clinical Database Management Professional Vacancy @ Teva

Pharma Production Executive Post Vacancy @ Intas

Biotecnika Times – Newsletter 28.02.2020 – DST Women Scientist WOS B, DBT-IOC Recruitment